MEDIUM confidence: 100% data completeness, but the composite (50) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $96.3B— | $97.1B+0.8% | $86.4B-11.0% | $83.7B-3.1% | $86.3B+3.1% |
| EPS (dil.) | $12.03— | $10.17-15.5% | $13.20+29.8% | $12.23-7.3% | $11.85-3.1% |
| Free Cash Flow | $8.3B— | $6.8B-18.2% | $6.2B-8.6% | $7.7B+24.6% | $7.7B-0.6% |
| Gross Margin | 31.6% | 31.4%-0.2pp | 31.4%-0.0pp | 31.2%-0.2pp | 33.5%+2.2pp |
| Operating Margin | 12.7% | 13.0%+0.3pp | 13.4%+0.3pp | 12.1%-1.3pp | 11.8%-0.3pp |
| Net Margin | 8.8% | 6.6%-2.1pp | 8.9%+2.3pp | 8.3%-0.6pp | 7.7%-0.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $259 avg across 6 analysts.
Buy-rated share 63% → 69% over ~3 months (+5pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| May 2026 | $2.97 | $3.03 | +2.0% |
| Feb 2026 | $1.94 | $1.98 | +2.1% |
| Nov 2025 | $2.97 | $3.06 | +3.0% |
| Aug 2025 | $4.24 | $4.33 | +2.1% |
| May 2025 | $2.88 | $2.92 | +1.4% |
| Feb 2025 | $1.84 | $1.93 | +4.9% |
| Nov 2024 | $2.81 | $2.89 | +2.8% |
| Aug 2024 | $3.97 | $4.10 | +3.3% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 3.3%/yr (revenue basis).
Base free cash flow $7.2B (avg FY2023–FY2025; latest year $7.7B) · equity value $121.3B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$8.5M over 180 days (0 open-market buys, 4 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 50 indicates a neutral outlook for Lowe's Companies, with neither strong positives nor negatives dominating the analysis. The stock scores relatively low on value, growth, and momentum, due to factors such as a moderate P/E of 18.3 and negative EPS growth of -3.1% over the past year. In contrast, it exhibits lower risk, with a beta of 0.9 and relatively low volatility, which helps to offset some of the negative factors. Overall, the score suggests a balanced profile with no significant divergence between long-term and short-term prospects.